Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Under US law, compounding pharmacies can make ... which are both based on the GLP-1 receptor agonist. Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts by Novo ...

That means compounded versions of semaglutide – the active ingredient in Novo Nordisk's Ozempic and Rybelsus for ... The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

As with Ozempic, it is not registered for weight management. Sahpra says it is concerned about the proliferation of ...

Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.